4/A: Organon & Co. Executive Trades Common Stock
Statement of Changes in Beneficial Ownership
Lynette Holzbaur, SVP and Corporate Controller at Organon & Co., reported transactions involving the acquisition and subsequent sale of company common stock.
Summary
- Lynette Holzbaur, SVP and Corporate Controller of Organon & Co., has reported transactions related to the company's common stock.
- On May 6, 2026, Ms. Holzbaur acquired 45.939 shares of common stock, which were not previously reported.
- Also on May 6, 2026, Ms. Holzbaur sold 26,448.366 shares of common stock at a price of $13.3498 per share.
- The filing is an amendment to a previous filing dated May 7, 2026, clarifying the nature of the transaction involving the 26,448.366 shares as a sale rather than a purchase.
Sentiment
Score: 4
Explanation: StockSavvy.ai views this filing neutrally to slightly negatively due to the significant sale of shares by a senior executive, although it is a standard disclosure and the reasons for the sale are not provided.
Negatives
- A significant disposition of 26,448.366 shares of common stock by a senior executive.
Future Outlook
No forward-looking statements or guidance are present in this filing.
Industry Context
StockSavvy.ai notes that Form 4 filings are standard disclosures for insider transactions. The sale of a substantial number of shares by a senior executive can sometimes be interpreted by the market, though the context of the transaction (e.g., pre-planned sale, diversification) is crucial for a complete understanding.
Stakeholder Impact
- Shareholders may observe the sale of a significant number of shares by a senior executive, potentially leading to questions about the executive's confidence in the company's future performance, though no specific reasons for the sale are provided.
Key Dates
| Date | Description |
|---|---|
| 05/06/2026 | Earliest transaction date reported; acquisition of 45.939 shares and sale of 26,448.366 shares. |
| 05/07/2026 | Date of original filing and date of amendment filing. |
Keywords
Organon & Co., OGN, Form 4, Insider Trading, Stock Transaction, Lynette Holzbaur, Common Stock, Securities Exchange Act
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.